Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robberecht

Showing results (111-120 of 772) with videos related to

Pageof 78
Sort By:
Archives of Neurology|January 12, 2011
Unilateral white matter involvement in Krabbe diseaseRobin Lemmens, Frans Piessens, Philippe Demaerel, et al.
Genome Medicine|July 31, 2010
Piecing together the problems in diagnosing low-level chromosomal mosaicismCaroline Robberecht, Jean-Pierre Fryns, Joris Robert Vermeesch
Journal of Cyclic Nucleotide Research|January 1, 1981
Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranesM Waelbroeck, P Robberecht, P Chatelain, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1990
Heterogeneity of VIP receptorsP Robberecht, A Cauvin, P Gourlet, et al.
European Journal of Biochemistry|October 5, 1990
Secretin receptors in the neuroglioma hybrid cell line NG108-15. Characterization and regulation of their expressionD Gossen, M Tastenoy, P Robberecht, et al.
The Prostate|August 10, 1999
Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranesM G Juarranz, P De Neef, P Robberecht
European Journal of Pharmacology|November 27, 1998
Influence of selective VIP receptor agonists in the rat gastric fundusP Robberecht, P De Neef, R A Lefebvre
Neuroreport|October 6, 1998
Tissue-type plasminogen activator is not required for kainate-induced motoneuron death in vitroW Vandenberghe, L Van Den Bosch, W Robberecht
Neurology|October 29, 2003
Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALSDavid Cassiman, Michiel Thomeer, Erik Verbeken, et al.
Peptides|March 24, 2006
Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptorChristelle Langlet, Ingrid Nachtergael, Patrick Robberecht, et al.
Pageof 78

Showing results (111-120 of 772) with videos related to

Sort By:
Pageof 78
Archives of Neurology|January 12, 2011
Unilateral white matter involvement in Krabbe diseaseRobin Lemmens, Frans Piessens, Philippe Demaerel, et al.
Genome Medicine|July 31, 2010
Piecing together the problems in diagnosing low-level chromosomal mosaicismCaroline Robberecht, Jean-Pierre Fryns, Joris Robert Vermeesch
Journal of Cyclic Nucleotide Research|January 1, 1981
Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranesM Waelbroeck, P Robberecht, P Chatelain, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1990
Heterogeneity of VIP receptorsP Robberecht, A Cauvin, P Gourlet, et al.
European Journal of Biochemistry|October 5, 1990
Secretin receptors in the neuroglioma hybrid cell line NG108-15. Characterization and regulation of their expressionD Gossen, M Tastenoy, P Robberecht, et al.
The Prostate|August 10, 1999
Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranesM G Juarranz, P De Neef, P Robberecht
European Journal of Pharmacology|November 27, 1998
Influence of selective VIP receptor agonists in the rat gastric fundusP Robberecht, P De Neef, R A Lefebvre
Neuroreport|October 6, 1998
Tissue-type plasminogen activator is not required for kainate-induced motoneuron death in vitroW Vandenberghe, L Van Den Bosch, W Robberecht
Neurology|October 29, 2003
Hypersensitivity pneumonitis possibly caused by riluzole therapy in ALSDavid Cassiman, Michiel Thomeer, Erik Verbeken, et al.
Peptides|March 24, 2006
Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptorChristelle Langlet, Ingrid Nachtergael, Patrick Robberecht, et al.
Pageof 78